首页 | 本学科首页   官方微博 | 高级检索  
     

自身免疫性肝病免疫学发病机制研究进展
引用本文:马雄,邱德凯. 自身免疫性肝病免疫学发病机制研究进展[J]. 胃肠病学, 2009, 14(4): 195-197. DOI: 10.3969/j.issn.1008-7125.2009.04.002
作者姓名:马雄  邱德凯
作者单位:上海交通大学医学院附属仁济医院消化内科,上海市消化疾病研究所,200001
摘    要:近年自身免疫性肝病(AILD)免疫学发病机制的研究取得了一定的突破,特别是对自身免疫性肝炎(AIH)和原发性胆汁性肝硬化(PBC)发病机制的研究较为深入。自身抗原的发现是开发高效、特异的AILD诊断方法的基础,亦为探索抗原特异性免疫治疗方法如口服耐受、T细胞疫苗等提供了可能。对肝内免疫调节异常.特别是调节性T细胞与Th17细胞平衡失调进行调控,可恢复AILD患者的免疫自稳状态,缓解炎症反应。

关 键 词:自身免疫性肝病  自身抗原  T淋巴细胞  自身反应性  T淋巴细胞  调节性  T淋巴细胞  辅助诱导

Advances in Studies on Immunopathogenesis of Autoirmnune Liver Disease
MA Xiong,QIU Dekai. Advances in Studies on Immunopathogenesis of Autoirmnune Liver Disease[J]. Chinese Journal of Gastroenterology, 2009, 14(4): 195-197. DOI: 10.3969/j.issn.1008-7125.2009.04.002
Authors:MA Xiong  QIU Dekai
Affiliation:( Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University School of Medicine Shanghai Institute of Digestive Disease, Shanghai 200001)
Abstract:Recently, there are many breakthroughs in the study of immunopathogenesis of autoimmune liver disease (AILD), especially autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC). Identification of autoantigens in AILD will provide opportunities to develop not only high performance and specific diagnostic methods, but also antigen-specific immunotherapy such as oral tolerance and T cell vaccination. Normalizing the abnormalities of immunoregulation in the liver, especially the imbalance of regulatory T cells and Thl7 cells, may improve the immune homeostasis and attenuate the inflammatory reaction in patients with AILD.
Keywords:Autoimmune Liver Diseases  Autoantigens  T-Lymphocytes, Autoreactive  T-Lymphocytes, Regulatory  T-Lymphocytes, Helper-lnducer
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号